연구동향 분석

Incidence, Clinical Features, and Prognostic Impact of CALR Exon 9 Mutations in Essential Thrombocythemia and Primary Myelofibrosis: An Experience of a Single Tertiary Hospital in Korea

박상혁 장철훈 김형회 김신영 이선민 이종윤 김인숙 이은엽 ChulhunLudgerusChang 송문곤 신호진 2015년

논문상세정보
인용/피인용
' Incidence, Clinical Features, and Prognostic Impact of CALR Exon 9 Mutations in Essential Thrombocythemia and Primary Myelofibrosis: An Experience of a Single Tertiary Hospital in Korea' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • calr
  • clinicalfeature
  • essentialthrombocythemia
  • incidence
  • mutation
  • primary myelofibrosis
  • prognosis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
8,159 0

0.0%

' Incidence, Clinical Features, and Prognostic Impact of CALR Exon 9 Mutations in Essential Thrombocythemia and Primary Myelofibrosis: An Experience of a Single Tertiary Hospital in Korea' 의 참고문헌

  • WHO classification of tumours of haematopoietic and lymphoid tissues
    Swerdlow SH IARC [2008]
  • WHO classification of tumours of haematopoietic and lymphoid tissues
    Swerdlow SH - [2008]
  • V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis
    Campbell PJ Blood 107 : 2098 ~ 2100 [2006]
  • V617F mutation in JAK2 is associated with poorer survival in idiopathic myelofibrosis
    Campbell PJ Blood 107 2098-2100 [2006]
  • Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients
    Butcher CM Leukemia 22 : 870 ~ 873 [2008]
  • Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients
    Butcher CM Leukemia 22 870-873 [2008]
  • Somatic mutations of calreticulin in myeloproliferative neoplasms
    Klampfl T N Engl J Med 369 : 2379 ~ 2390 [2013]
  • Somatic mutations of calreticulin in myeloproliferative neoplasms
    Klampfl T N Engl J Med 369 2379-2390 [2013]
  • Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2
    Nangalia J N Engl J Med 369 : 2391 ~ 2405 [2013]
  • Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2
    Nangalia J N Engl J Med 369 2391-2405 [2013]
  • Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history
    Gangat N Eur J Haematol [2014]
  • Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history
    Gangat N Eur J Haematol - [2014]
  • Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations
    Bench AJ Br J Haematol 160 : 25 ~ 34 [2013]
  • Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutations
    Bench AJ Br J Haematol 160 25-34 [2013]
  • Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations
    Passamonti F Blood 117 : 2813 ~ 2816 [2011]
  • Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations
    Passamonti F Blood 117 2813-2816 [2011]
  • JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
    Rumi E Blood 123 : 1544 ~ 1551 [2014]
  • JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes
    Rumi E Blood 123 1544-1551 [2014]
  • JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis
    Scott LM N Engl J Med 356 : 459 ~ 468 [2007]
  • JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis
    Scott LM N Engl J Med 356 459-468 [2007]
  • Frequencies, clinical characteristics, and outcome of somatic CALR mutations in JAK2-unmutated essential thrombocythemia
    Chen CC Ann Hematol [2014]
  • Frequencies, clinical characteristics, and outcome of somatic CALR mutations in JAK2-unmutated essential thrombocythemia
    Chen CC Ann Hematol - [2014]
  • Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study
    Campbell PJ Lancet 366 : 1945 ~ 1953 [2005]
  • Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study
    Campbell PJ Lancet 366 1945-1953 [2005]
  • Calreticulin mutations in Chinese with primary myelofibrosis
    Li B Haematologica 99 : 1697 ~ 1700 [2014]
  • Calreticulin mutations in Chinese with primary myelofibrosis
    Li B Haematologica 99 1697-1700 [2014]
  • CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
    Tefferi A Leukemia 28 : 1472 ~ 1477 [2014]
  • CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons
    Tefferi A Leukemia 28 1472-1477 [2014]
  • CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis
    Rumi E Blood 123 : 2416 ~ 2419 [2014]
  • CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis
    Rumi E Blood 123 2416-2419 [2014]
  • CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
    Tefferi A Leukemia 28 : 1494 ~ 1500 [2014]
  • CALR and ASXL1 mutations-based molecular prognostication in primary myelofibrosis: an international study of 570 patients
    Tefferi A Leukemia 28 1494-1500 [2014]
  • CALR and ASXL1 mutation analysis in 190 patients with essential thrombocythemia
    Shen H Leuk Lymphoma 13 : 1 ~ 3 [2014]
  • CALR and ASXL1 mutation analysis in 190 patients with essential thrombocythemia
    Shen H Leuk Lymphoma 13 1-3 [2014]
  • Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative. Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms
    Rumi E Blood 121 : 4388 ~ 4395 [2013]
  • Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative. Acquired copy-neutral loss of heterozygosity of chromosome 1p as a molecular event associated with marrow fibrosis in MPL-mutated myeloproliferative neoplasms
    Rumi E Blood 121 4388-4395 [2013]
  • An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms
    Tefferi A Leukemia 28 : 1407 ~ 1413 [2014]
  • An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms
    Tefferi A Leukemia 28 1407-1413 [2014]
  • A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
    Passamonti F Blood 115 : 1703 ~ 1708 [2010]
  • A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)
    Passamonti F Blood 115 1703-1708 [2010]